Tuesday, June 2, 2020

Horseshoe crab blood remains industry standard for big pharma

It’s a bad week for horseshoe crabs as their defenders have failed to convince big pharma that synthetic crab blood is a viable alternative for endotoxin testing in drugs.

from Inhabitat - Green Design, Innovation, Architecture, Green Building https://inhabitat.com/horseshoe-crab-blood-remains-industry-standard-for-big-pharma
via Inhabitat

No comments:

Post a Comment